Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed Dose Combination Administered in Patients Infected With Chronic Genotype 1 or 4 HCV for Use in the Peri-Operative Liver Transplantation Setting

Name: Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed Dose Combination Administered in Patients Infected With Chronic Genotype 1 or 4 HCV for Use in the Peri-Operative Liver Transplantation Setting
Published: 2015
License: Public Domain

Gilead Sciences · 2015

ClinicalTrials.gov · Datasets · License: Public Domain · 2015

Open Source ↗

communicable-diseases hepatitis-c infection liver-diseases

hepatitis c virus infection, liver transplant, hepatitis c, gilead, communicable diseases, infection, liver diseases, rna virus infections, interventional, phase2

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed Dose Combination Administered in Patients Infected With Chronic Genotype 1 or 4 HCV for Use in the Peri-Operative Liver Transplantation Setting

Related documents